Mitochondrial inner membrane and oxidative phosphorylation machinery (OXPHOS)

The mitochondrial inner membrane and oxidative phosphorylation (OXPHOS) machinery represent the central hub for cellular energy production via the electron transport chain (ETC) and ATP synthase. This system consists of five multi-protein complexes (Complexes I-V) embedded within the inner mitochondrial membrane, which facilitate the transfer of electrons and the pumping of protons to generate a transmembrane electrochemical gradient (StatPearls, NBK526105). This gradient is subsequently utilized by ATP synthase to phosphorylate ADP into ATP, the primary energy currency of the cell. Beyond energy production, the OXPHOS machinery is a major source of reactive oxygen species (ROS) and plays a pivotal role in the intrinsic pathway of apoptosis and calcium signaling (PubMed, PMID: 19648510). Dysfunction in these processes is a hallmark of various conditions, including primary mitochondrial diseases, neurodegeneration, and metabolic disorders like type 2 diabetes (PubMed, PMID: 22303313). In cancer, recent evidence suggests many tumors rely on mitochondrial respiration for survival and metastasis, leading to the development of OXPHOS inhibitors like atovaquone (PubMed, PMID: 26361210). Therapeutic targeting of this machinery requires careful management due to the potential for systemic toxicity, most notably lactic acidosis and off-target effects in high-energy organs such as the heart and brain (PubMed, PMID: 25114300).

Other names

Electron transport chainRespiratory chainETCMitochondrial respiratory chain

Drugs targeting this machinery primarily act by inhibiting specific complexes of the electron transport chain (e.g., Complex I inhibition by metformin), uncoupling the proton gradient from ATP synthesis, or directly inhibiting ATP synthase (Complex V), thereby disrupting cellular energy metabolism and inducing metabolic stress (PubMed, PMID: 10839993; PMID: 26361210).